ATE262905T1 - Pharmazeutische formulierungen in hydroxypropylmethylcellulose-kapseln - Google Patents

Pharmazeutische formulierungen in hydroxypropylmethylcellulose-kapseln

Info

Publication number
ATE262905T1
ATE262905T1 AT00947971T AT00947971T ATE262905T1 AT E262905 T1 ATE262905 T1 AT E262905T1 AT 00947971 T AT00947971 T AT 00947971T AT 00947971 T AT00947971 T AT 00947971T AT E262905 T1 ATE262905 T1 AT E262905T1
Authority
AT
Austria
Prior art keywords
pharmaceutical formulations
hydroxypropylmethyl cellulose
cellulose capsules
capsules
hydroxypropylmethyl
Prior art date
Application number
AT00947971T
Other languages
English (en)
Inventor
Paola Civaroli
Lorena Muggetti
Alessandro Martini
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Application granted granted Critical
Publication of ATE262905T1 publication Critical patent/ATE262905T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00947971T 1999-08-10 2000-07-11 Pharmazeutische formulierungen in hydroxypropylmethylcellulose-kapseln ATE262905T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9918885.6A GB9918885D0 (en) 1999-08-10 1999-08-10 Pharmaceutical formulations in hydroxypropymethycellulose capsules
PCT/EP2000/006590 WO2001010443A1 (en) 1999-08-10 2000-07-11 Pharmaceutical formulations in hydroxypropylmethylcellulose capsules

Publications (1)

Publication Number Publication Date
ATE262905T1 true ATE262905T1 (de) 2004-04-15

Family

ID=10858930

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00947971T ATE262905T1 (de) 1999-08-10 2000-07-11 Pharmazeutische formulierungen in hydroxypropylmethylcellulose-kapseln

Country Status (18)

Country Link
US (1) US6569452B1 (de)
EP (1) EP1126851B1 (de)
CN (1) CN1245976C (de)
AR (1) AR025060A1 (de)
AT (1) ATE262905T1 (de)
AU (1) AU6158200A (de)
CA (1) CA2354039C (de)
CO (1) CO5200854A1 (de)
CZ (1) CZ293749B6 (de)
DE (1) DE60009442D1 (de)
EA (1) EA200100568A1 (de)
GB (1) GB9918885D0 (de)
HK (1) HK1040930B (de)
HU (1) HUP0104476A3 (de)
IL (2) IL143502A0 (de)
NO (1) NO319712B1 (de)
PE (1) PE20010407A1 (de)
WO (1) WO2001010443A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9925127D0 (en) * 1999-10-22 1999-12-22 Pharmacia & Upjohn Spa Oral formulations for anti-tumor compounds
CN1316970C (zh) * 2002-11-14 2007-05-23 武汉华中科大纳米药业有限公司 一种羟喜树碱固体分散物及其制剂
JP2005183361A (ja) * 2003-10-03 2005-07-07 Ngk Insulators Ltd 電子放出素子、電子放出装置、ディスプレイ及び光源
US20050208146A1 (en) * 2003-10-30 2005-09-22 Pfizer Inc Novel dosage and administration method for oral camptosar
GT200500310A (es) 2004-11-19 2006-06-19 Compuestos organicos
SA06270147B1 (ar) 2005-06-09 2009-12-22 نوفارتيس ايه جي عملية لتخليق 5-(مثيل–1h–إيميدازول–1-يل )–3-(ثلاثي فلـورو مثيل)–بنزامـين
WO2007033522A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation de gélule contenant de la moxifloxacine et son procédé de préparation
GB0526419D0 (en) * 2005-12-23 2006-02-08 Cyclacel Ltd Formulation
EP2086513B1 (de) * 2006-09-26 2016-09-07 Samyang Biopharmaceuticals Corporation Submikron-nanoteilchen von schwer wasserlöslichen camptothecin-derivaten und herstellungsverfahren dafür
CA2844367C (en) * 2011-06-24 2016-02-16 Acenda Pharma, Inc. Method and improved pharmaceutical composition for improving the absorption of an ester prodrug
CN103110605A (zh) * 2011-11-17 2013-05-22 天士力制药集团股份有限公司 一种热熔胶囊制剂及其制备方法
US10143657B2 (en) 2014-01-17 2018-12-04 Oncoral Pharma Aps Solid oral dosage form of irinotecan for the treatment of cancer
CN105287427B (zh) * 2015-10-20 2017-04-19 沈阳红旗制药有限公司 一种利福平半固体胶囊及其制备方法
KR102066402B1 (ko) * 2017-12-22 2020-01-15 대화제약 주식회사 이리노테칸 또는 그의 약제학적으로 허용가능한 염을 포함하는 경구투여용 약제학적 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678516A (en) * 1984-10-09 1987-07-07 The Dow Chemical Company Sustained release dosage form based on highly plasticized cellulose ether gels
EP0758237B1 (de) * 1994-04-28 2003-08-27 Bionumerik Pharmaceuticals, Inc. Lactone-stabile camptothecin oder 7 - ethyl camptothecin - formulierung in dimethylisosorbid oder dimethylacetamid
US5597829A (en) 1994-05-09 1997-01-28 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of camptothecin and methods for uses thereof
US5756123A (en) * 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
US5726181A (en) * 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
KR20000029784A (ko) * 1996-08-02 2000-05-25 나까도미 히로다카 경구제제용캡슐과경구캡슐제제
AR013261A1 (es) * 1997-08-01 2000-12-13 Smithkline Beecham Corp Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina

Also Published As

Publication number Publication date
NO20013205L (no) 2001-06-26
DE60009442D1 (de) 2004-05-06
EA200100568A1 (ru) 2001-10-22
HUP0104476A3 (en) 2004-05-28
CZ293749B6 (cs) 2004-07-14
EP1126851A1 (de) 2001-08-29
HK1040930A1 (en) 2002-06-28
AR025060A1 (es) 2002-11-06
PE20010407A1 (es) 2001-03-28
CZ20012089A3 (cs) 2001-10-17
IL143502A (en) 2006-12-10
HUP0104476A2 (hu) 2002-03-28
HK1040930B (zh) 2006-10-27
EP1126851B1 (de) 2004-03-31
GB9918885D0 (en) 1999-10-13
CN1327387A (zh) 2001-12-19
WO2001010443A1 (en) 2001-02-15
NO20013205D0 (no) 2001-06-26
AU6158200A (en) 2001-03-05
CA2354039A1 (en) 2001-02-15
CN1245976C (zh) 2006-03-22
NO319712B1 (no) 2005-09-05
CO5200854A1 (es) 2002-09-27
IL143502A0 (en) 2002-04-21
US6569452B1 (en) 2003-05-27
CA2354039C (en) 2008-09-23

Similar Documents

Publication Publication Date Title
DE69812089D1 (de) Pharmazeutische omeprazol-formulierung
ATE238812T1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
DE50014244D1 (de) Pharmazeutische tramadolsalze
EE200000383A (et) Peroraalne farmatseutiline pikendatud vabanemisega annusvorm
EE200000395A (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm
EE200200097A (et) Bensamiididerivaati sisaldav farmatseutiline preparaat
ATE404180T1 (de) Geschmacksmaskierte pharmazeutische partikel
FIU20000164U0 (fi) Uusi farmaseuttinen formulaatio
ATE432707T1 (de) Pharmazeutische zubereitung
ATE262905T1 (de) Pharmazeutische formulierungen in hydroxypropylmethylcellulose-kapseln
NO20015670D0 (no) Forbedrede farmasöytiske formuleringer
NO20014738D0 (no) Tolperisonholdig farmasöytisk preparat for oral administrering
DE60037816D1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
DE59910298D1 (de) Pharmazeutische levothyroxinzubereitung
NO20015148L (no) Nytt farmasöytisk preparat
DE10084344T1 (de) Cyclosporin enthaltende pharmazeutische Zusammensetzung
EE200200073A (et) Bensamiididerivaati sisaldav farmatseutiline preparaat
NO20015104D0 (no) Nytt farmasöytisk preparat
NO20015105D0 (no) Nytt farmasöytisk preparat
NO20004816D0 (no) Ny farmasøytisk formulering
DE19681529D2 (de) Pharmazeutische Darreichungsform
DE60001768D1 (de) Tezosentan enthaltende wässerige pharmazeutische Zubereitung
NO20003284D0 (no) Farmasøytisk preparat for oral administrering
ATA77096A (de) Pharmazeutische präparation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties